 | • レポートコード：C-GIR011666 • 出版社/出版日：GlobalInfoResearch / 2018年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール • 産業分類：医療・バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートでは、皮膚科学薬品の世界市場について調査・分析し、皮膚科学薬品の世界市場概観、メーカー動向、メーカー別皮膚科学薬品シェア、市場規模推移、市場規模予測、皮膚科学薬品種類別分析（処方箋ベースの薬、市販薬）、皮膚科学薬品用途別分析（にきび、皮膚感染症、乾癬、皮膚炎の薬、その他）、主要地域分析（北米、欧州、アジア）、主要国分析データなどを含め、以下の構成でお届け致します。 ・皮膚科学薬品の市場概観 ・皮膚科学薬品のメーカー概要（事業概要、製品種類、価格、売上、市場シェア等） ・皮膚科学薬品のメーカー別販売動向、市場シェア、市場集中度、競争動向 ・皮膚科学薬品の世界市場規模 ・皮膚科学薬品の北米市場分析（アメリカ、カナダ、メキシコ等） ・皮膚科学薬品のアメリカ市場規模推移 ・皮膚科学薬品のカナダ市場規模推移 ・皮膚科学薬品のメキシコ市場規模推移 ・皮膚科学薬品のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・皮膚科学薬品のドイツ市場規模推移 ・皮膚科学薬品のイギリス市場規模推移 ・皮膚科学薬品のロシア市場規模推移 ・皮膚科学薬品のアジア市場分析（日本、中国、韓国、インド、東南アジア等） ・皮膚科学薬品の日本市場規模推移 ・皮膚科学薬品の中国市場規模推移 ・皮膚科学薬品の韓国市場規模推移 ・皮膚科学薬品のインド市場規模推移 ・皮膚科学薬品の東南アジア市場規模推移 ・皮膚科学薬品の南米・中東・アフリカ市場分析 ・皮膚科学薬品の種類別分析/市場規模推移（処方箋ベースの薬、市販薬） ・皮膚科学薬品の用途別分析/市場規模推移（にきび、皮膚感染症、乾癬、皮膚炎の薬、その他） ・皮膚科学薬品の市場予測（地域別予測、種類別予測、用途別予測） ・皮膚科学薬品の販売チャネル・代理店・貿易業者・ディーラー分析 |
Dermatology is a field of medicine that is engaged in the diagnosis, prevention, and treatment of various skin, nails, hair diseases, pigmentation, acne, wrinkles, psoriasis, and others.
Scope of the Report:
This report focuses on the Dermatological Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Different techniques are used in dermatology such as topical & systemic medications, laser therapy, radio therapy, photodynamic therapy, vitiligo surgery, dermatological surgery, and others.
The worldwide market for Dermatological Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Bayer
Johnson & Johnson
Pfizer
Novartis
GlaxoSmithKline
AstraZeneca
Galderma
Amgen
AbbVie
Merck
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Prescription-Based Drugs
Over-the-Counter Drugs
Market Segment by Applications, can be divided into
Acne
Skin Infections
Psoriasis
Dermatitis Drugs
Other
There are 15 Chapters to deeply display the global Dermatological Drugs market.
Chapter 1, to describe Dermatological Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Dermatological Drugs, with sales, revenue, and price of Dermatological Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Dermatological Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Dermatological Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Dermatological Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
レポート目次Table of Contents
1 Market Overview
1.1 Dermatological Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Prescription-Based Drugs
1.2.2 Over-the-Counter Drugs
1.3 Market Analysis by Applications
1.3.1 Acne
1.3.2 Skin Infections
1.3.3 Psoriasis
1.3.4 Dermatitis Drugs
1.3.5 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Dermatological Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Dermatological Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Dermatological Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Dermatological Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 GlaxoSmithKline
2.5.1 Business Overview
2.5.2 Dermatological Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GlaxoSmithKline Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 AstraZeneca
2.6.1 Business Overview
2.6.2 Dermatological Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AstraZeneca Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Galderma
2.7.1 Business Overview
2.7.2 Dermatological Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Galderma Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Amgen
2.8.1 Business Overview
2.8.2 Dermatological Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Amgen Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 AbbVie
2.9.1 Business Overview
2.9.2 Dermatological Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 AbbVie Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Merck
2.10.1 Business Overview
2.10.2 Dermatological Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Merck Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Dermatological Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Dermatological Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Dermatological Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Dermatological Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Dermatological Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Dermatological Drugs Market Analysis by Regions
4.1 Global Dermatological Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Dermatological Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Dermatological Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Dermatological Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Dermatological Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Dermatological Drugs Sales and Growth Rate (2013-2018)
4.5 South America Dermatological Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Dermatological Drugs Sales and Growth Rate (2013-2018)
5 North America Dermatological Drugs by Countries
5.1 North America Dermatological Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Dermatological Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Dermatological Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Dermatological Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Dermatological Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Dermatological Drugs Sales and Growth Rate (2013-2018)
6 Europe Dermatological Drugs by Countries
6.1 Europe Dermatological Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Dermatological Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Dermatological Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Dermatological Drugs Sales and Growth Rate (2013-2018)
6.3 UK Dermatological Drugs Sales and Growth Rate (2013-2018)
6.4 France Dermatological Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Dermatological Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Dermatological Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Dermatological Drugs by Countries
7.1 Asia-Pacific Dermatological Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Dermatological Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Dermatological Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Dermatological Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Dermatological Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Dermatological Drugs Sales and Growth Rate (2013-2018)
7.5 India Dermatological Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Dermatological Drugs Sales and Growth Rate (2013-2018)
8 South America Dermatological Drugs by Countries
8.1 South America Dermatological Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Dermatological Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Dermatological Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Dermatological Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Dermatological Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Dermatological Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Dermatological Drugs by Countries
9.1 Middle East and Africa Dermatological Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Dermatological Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Dermatological Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Dermatological Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Dermatological Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Dermatological Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Dermatological Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Dermatological Drugs Sales and Growth Rate (2013-2018)
10 Global Dermatological Drugs Market Segment by Type
10.1 Global Dermatological Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Dermatological Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Dermatological Drugs Revenue and Market Share by Type (2013-2018)
10.2 Prescription-Based Drugs Sales Growth and Price
10.2.1 Global Prescription-Based Drugs Sales Growth (2013-2018)
10.2.2 Global Prescription-Based Drugs Price (2013-2018)
10.3 Over-the-Counter Drugs Sales Growth and Price
10.3.1 Global Over-the-Counter Drugs Sales Growth (2013-2018)
10.3.2 Global Over-the-Counter Drugs Price (2013-2018)
11 Global Dermatological Drugs Market Segment by Application
11.1 Global Dermatological Drugs Sales Market Share by Application (2013-2018)
11.2 Acne Sales Growth (2013-2018)
11.3 Skin Infections Sales Growth (2013-2018)
11.4 Psoriasis Sales Growth (2013-2018)
11.5 Dermatitis Drugs Sales Growth (2013-2018)
11.6 Other Sales Growth (2013-2018)
12 Dermatological Drugs Market Forecast (2018-2023)
12.1 Global Dermatological Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Dermatological Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Dermatological Drugs Market Forecast (2018-2023)
12.2.2 Europe Dermatological Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Dermatological Drugs Market Forecast (2018-2023)
12.2.4 South America Dermatological Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Dermatological Drugs Market Forecast (2018-2023)
12.3 Dermatological Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Dermatological Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Dermatological Drugs Market Share Forecast by Type (2018-2023)
12.4 Dermatological Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Dermatological Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Dermatological Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and FiguresFigure Dermatological Drugs Picture
Table Product Specifications of Dermatological Drugs
Figure Global Sales Market Share of Dermatological Drugs by Types in 2017
Table Dermatological Drugs Types for Major Manufacturers
Figure Prescription-Based Drugs Picture
Figure Over-the-Counter Drugs Picture
Figure Dermatological Drugs Sales Market Share by Applications in 2017
Figure Acne Picture
Figure Skin Infections Picture
Figure Psoriasis Picture
Figure Dermatitis Drugs Picture
Figure Other Picture
Figure United States Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Dermatological Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Dermatological Drugs Type and Applications
Table Bayer Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Dermatological Drugs Type and Applications
Table Johnson & Johnson Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Dermatological Drugs Type and Applications
Table Pfizer Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Dermatological Drugs Type and Applications
Table Novartis Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Dermatological Drugs Type and Applications
Table GlaxoSmithKline Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Dermatological Drugs Type and Applications
Table AstraZeneca Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Galderma Basic Information, Manufacturing Base and Competitors
Table Galderma Dermatological Drugs Type and Applications
Table Galderma Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Dermatological Drugs Type and Applications
Table Amgen Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Dermatological Drugs Type and Applications
Table AbbVie Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Dermatological Drugs Type and Applications
Table Merck Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Dermatological Drugs Sales by Manufacturer (2016-2017)
Figure Global Dermatological Drugs Sales Market Share by Manufacturer in 2016
Figure Global Dermatological Drugs Sales Market Share by Manufacturer in 2017
Table Global Dermatological Drugs Revenue by Manufacturer (2016-2017)
Figure Global Dermatological Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Dermatological Drugs Revenue Market Share by Manufacturer in 2017
Figure Top 3 Dermatological Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Dermatological Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Global Dermatological Drugs Revenue and Growth Rate (2013-2018)
Table Global Dermatological Drugs Sales by Regions (2013-2018)
Table Global Dermatological Drugs Sales Market Share by Regions (2013-2018)
Table Global Dermatological Drugs Revenue by Regions (2013-2018)
Figure Global Dermatological Drugs Revenue Market Share by Regions in 2013
Figure Global Dermatological Drugs Revenue Market Share by Regions in 2017
Figure North America Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Europe Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure South America Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure North America Dermatological Drugs Revenue and Growth Rate (2013-2018)
Table North America Dermatological Drugs Sales by Countries (2013-2018)
Table North America Dermatological Drugs Sales Market Share by Countries (2013-2018)
Figure North America Dermatological Drugs Sales Market Share by Countries in 2013
Figure North America Dermatological Drugs Sales Market Share by Countries in 2017
Table North America Dermatological Drugs Revenue by Countries (2013-2018)
Table North America Dermatological Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Dermatological Drugs Revenue Market Share by Countries in 2013
Figure North America Dermatological Drugs Revenue Market Share by Countries in 2017
Figure United States Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Canada Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Europe Dermatological Drugs Revenue and Growth Rate (2013-2018)
Table Europe Dermatological Drugs Sales by Countries (2013-2018)
Table Europe Dermatological Drugs Sales Market Share by Countries (2013-2018)
Table Europe Dermatological Drugs Revenue by Countries (2013-2018)
Figure Europe Dermatological Drugs Revenue Market Share by Countries in 2016
Figure Europe Dermatological Drugs Revenue Market Share by Countries in 2017
Figure Germany Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure UK Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure France Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Russia Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Italy Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Dermatological Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Dermatological Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Dermatological Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Dermatological Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Dermatological Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Dermatological Drugs Revenue Market Share by Countries 2017
Figure China Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Japan Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Korea Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure India Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure South America Dermatological Drugs Revenue and Growth Rate (2013-2018)
Table South America Dermatological Drugs Sales by Countries (2013-2018)
Table South America Dermatological Drugs Sales Market Share by Countries (2013-2018)
Figure South America Dermatological Drugs Sales Market Share by Countries in 2017
Table South America Dermatological Drugs Revenue by Countries (2013-2018)
Table South America Dermatological Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Dermatological Drugs Revenue Market Share by Countries in 2017
Figure Brazil Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Dermatological Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Dermatological Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Dermatological Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Dermatological Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Dermatological Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Dermatological Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Dermatological Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Dermatological Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure UAE Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Dermatological Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Dermatological Drugs Sales and Growth Rate (2013-2018)
Table Global Dermatological Drugs Sales by Type (2013-2018)
Table Global Dermatological Drugs Sales Share by Type (2013-2018)
Table Global Dermatological Drugs Revenue by Type (2013-2018)
Table Global Dermatological Drugs Revenue Share by Type (2013-2018)
Figure Global Prescription-Based Drugs Sales Growth (2013-2018)
Figure Global Prescription-Based Drugs Price (2013-2018)
Figure Global Over-the-Counter Drugs Sales Growth (2013-2018)
Figure Global Over-the-Counter Drugs Price (2013-2018)
Table Global Dermatological Drugs Sales by Application (2013-2018)
Table Global Dermatological Drugs Sales Share by Application (2013-2018)
Figure Global Skin Infections Sales Growth (2013-2018)
Figure Global Psoriasis Sales Growth (2013-2018)
Figure Global Dermatitis Drugs Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Dermatological Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Dermatological Drugs Sales Forecast by Regions (2018-2023)
Table Global Dermatological Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Dermatological Drugs Market Forecast (2018-2023)
Figure Europe Sales Dermatological Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Dermatological Drugs Market Forecast (2018-2023)
Figure South America Sales Dermatological Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Dermatological Drugs Market Forecast (2018-2023)
Table Global Dermatological Drugs Sales Forecast by Type (2018-2023)
Table Global Dermatological Drugs Market Share Forecast by Type (2018-2023)
Table Global Dermatological Drugs Sales Forecast by Application (2018-2023)
Table Global Dermatological Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List